| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Historical Data Period | 2019 - 2023 |
| Market Size (2025) | USD 2.20 Billion |
| Market Size (2030) | USD 3.20 Billion |
| CAGR (2025 - 2030) | 7.82% |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Italy Patient Monitoring Market Analysis by Mordor Intelligence
The Italy Patient Monitoring Market size is estimated at USD 2.20 billion in 2025, and is expected to reach USD 3.20 billion by 2030, at a CAGR of 7.82% during the forecast period (2025-2030).
Globally, the COVID-19 pandemic resulted in enormous pressures on the healthcare systems and hospitals as most of the healthcare settings were understaffed and overworked. Patient monitoring devices, such as ventilators, helped in the monitoring of critically ill COVID-19 patients, which allowed the measurements of physiological reserves and indications of the effectiveness of therapeutic interventions during the pandemic, showing a positive impact on the market. Furthermore, the companies increased their manufacturing of critical and essential medical device products. For instance, in March 2020, Royal Philips ramped up the production of certain critical care products and solutions that help in detecting and providing treatment for patients with COVID-19. The product line included patient vital signs monitors, medical consumables for non-invasive and invasive ventilation, and portable ventilators to treat respiratory conditions. Thus, owing to the aforementioned factors, the market experienced a positive impact during the pandemic phase.
Furthermore, the growth of the patient monitoring market is attributed to the rising burden of chronic diseases due to lifestyle changes, growth in the geriatric population, growing preference for home and remote monitoring, and the ease of use of portable devices.
According to the World Population Ageing 2021 report, in 2021, 23.4% of the total population in Italy was 65 years and older. According to data, the share of elderly people in the Italian society has been growing constantly in recent years. Consequently, the share of young population experienced a decrease in the last years. As a result, the average age of Italians has risen. Thus, an increasing number of the geriatric population who are more prone to chronic diseases is expected to drive the market as this population requires monitoring devices in the management of diseases.
According to the article 'Diabetein Italia, una crescitadel 60 per cento in vent'anni' published in February 2021, more than 3.5 million adults in Italy are diabetic, showing a growth of 60% from 2000 to 2019. The leading cause of diabetes in Italy is the aging population, accompanied by increasingly sedentary lifestyles and an increase in overweight or obesity, thus there is an increasing demand for patient monitoting in the nation.
Additionally, according to the Eurostat healthcare expenditure statistics published in December 2021, Italy spent around EUR 155,249 million in the healthcare sector in the year 2019. Italy was the third highest nation spending on healthcare in Europe in 2019. The large expenditure in the healthcare in the nation are likely to boost the growth of the market over the forecast period.
Thus, owing to the above-mentioned factors it is expected to show significant growth over the forecast period.
Italy Patient Monitoring Market Trends and Insights
Hemodynamic Monitoring Devices Segment is Expected to Grow Fastest Over the Forecast Period
The major factors driving the growth of this segment include the rising burden of chronic diseases such as cardiovascular diseases and diabetes due to lifestyle changes.
According to the study published in March 2021, titled "Cardiovascular disease burden: Italian and global perspectives", the crude prevalence of CVD in Italy is nearly twofold higher than the global prevalence (12.9% vs. 6.6%), while age-standardized estimates are similar (6.2% vs. 6.3%). Of the evaluated cardiovascular conditions, the most important CVD burden is due to ischemic heart disease, which shows a crude prevalence of 3.6% in Italy, doubling the corresponding crude global estimate of 1.7%. Moreover, the high death rates of coronary heart disease are expected to show greater demand for hemodynamic patient monitoring devices which shows a positive impact on market growth. Thus, a high number of patients with heart diseases is expected to drive market growth over the forecast period.
Moreover, the Italian Society of Cardiovascular Prevention has structured new recommendations for people with heart diseases in Italy in which the relation between COVID-19 and heart diseases is spread across the general population. Additionally, the Italian Federation of Cardiology has highlighted the importance of quality cardiovascular devices. With this, the focus of Italian CVD-related organizations has increased concerning highly efficient devices that include hemodynamic monitoring devices as well. Therefore, it is expected that the demand for hemodynamic monitoring devices will be higher in Italy in the coming years.
Understand The Key Trends Shaping This Market
Download PDF
Competitive Landscape
The Italy patient monitoring market is consolidated competitive. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships that help them in strengthening their market position. Some of the market players are Koninklijke Philips NV, Nihon Kohden Corporation, GE Healthcare (GE Company), Abbott Laboratories, Dragerwerk AG & Co. KGaA, and others.
Italy Patient Monitoring Industry Leaders
-
General Electric Company (GE Healthcare)
-
Koninklijke Philips N.V.
-
Abbott Laboratories
-
Dragerwerk AG & Co. KGaA
-
Nihon Kohden Corporation
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF
Recent Industry Developments
- In August 2022, Kaiku Health's year-old alliance with Novartis to develop a digital patient monitoring and management (DPPM) system for patients with melanoma was extended. The initial partnership led to a pilot of the personalized support module for people being treated with the drugs at cancer clinics in Italy, alongside an established module from Kaiku.
- In April 2021, TytoCare partnered with Multimed which will exclusively introduce TytoCare to the Italian public healthcare market.
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now
Italy Patient Monitoring Market Report Scope
As per the scope of this report, patient monitoring devices are the monitoring devices that continuously monitor the patient's vital parameters, like blood pressure and heart rates, by using a medical monitor and collecting medical (and other) data from individuals. The Italy Patient Monitoring Market is Segmented by Type of Device (Hemodynamic Monitoring Devices, Neuromonitoring Devices, Cardiac Monitoring Devices, Multi-parameter Monitors, Respiratory Monitoring Devices, Remote Patient Monitoring Devices, and Other Types of Devices), Application (Cardiology, Neurology, Respiratory, Fetal and Neonatal, Weight Management and Fitness Monitoring, and Other Applications) and End-User (Home Healthcare, Hospitals and Clinics, and Other End Users). The report offers the value (in USD million) for the above segments.
By Type of Device
| Hemodynamic Monitoring Devices |
| Neuromonitoring Devices |
| Cardiac Monitoring Devices |
| Multi-parameter Monitors |
| Respiratory Monitoring Devices |
| Remote Patient Monitoring Devices |
| Other Types of Devices |
By Application
| Cardiology |
| Neurology |
| Respiratory |
| Fetal and Neonatal |
| Weight Management and Fitness Monitoring |
| Other Applications |
By End Users
| Home Healthcare |
| Hospitals and Clinics |
| Other End Users |
| By Type of Device | Hemodynamic Monitoring Devices |
| Neuromonitoring Devices | |
| Cardiac Monitoring Devices | |
| Multi-parameter Monitors | |
| Respiratory Monitoring Devices | |
| Remote Patient Monitoring Devices | |
| Other Types of Devices | |
| By Application | Cardiology |
| Neurology | |
| Respiratory | |
| Fetal and Neonatal | |
| Weight Management and Fitness Monitoring | |
| Other Applications | |
| By End Users | Home Healthcare |
| Hospitals and Clinics | |
| Other End Users |
Need A Different Region or Segment?
Customize Now
Key Questions Answered in the Report
How big is the Italy Patient Monitoring Market?
The Italy Patient Monitoring Market size is expected to reach USD 2.20 billion in 2025 and grow at a CAGR of 7.82% to reach USD 3.20 billion by 2030.
What is the current Italy Patient Monitoring Market size?
In 2025, the Italy Patient Monitoring Market size is expected to reach USD 2.20 billion.
Who are the key players in Italy Patient Monitoring Market?
General Electric Company (GE Healthcare), Koninklijke Philips N.V., Abbott Laboratories, Dragerwerk AG & Co. KGaA and Nihon Kohden Corporation are the major companies operating in the Italy Patient Monitoring Market.
What years does this Italy Patient Monitoring Market cover, and what was the market size in 2024?
In 2024, the Italy Patient Monitoring Market size was estimated at USD 2.03 billion. The report covers the Italy Patient Monitoring Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Italy Patient Monitoring Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Page last updated on:
Italy Patient Monitoring Market Report
Statistics for the 2025 Italy Patient Monitoring market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Italy Patient Monitoring analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
